Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arrigoni A, Gindro T, Aimo G, et al (1994) Mono-ethylglycinexylidide test: a prognostic indicator of survival in cirrhosis. Hepatology 20: 383–7
Balogh A, Harder S, Vollandt R, et al (1992) Intra-individual variability of caffeine elimination in healthy subjects. Int J Clin Pharmacol Ther Toxicol 30: 383–7 Published erratum appears in Int J Clin Pharmacol Ther Toxicol (1993) 3: 208
Bergstrom M, Soderman C, Eriksson LS (1993) A simplifi ed method to determine galactose elimination capacity in patients with liver disease. Scand J Clin Lab Invest 53: 667–70
Brockmöller J, Roots I (1994) Assessment of liver metabolic function. Clinical implications. Clin Pharmacokinet 27: 216–48
Brody DH, Leichter L (1979) Clearance tests of liver function. Med Clin North Am 63: 621–30
Caspary WF (1978) Atemanalytische Tests in der Leberfunktionsdiagnostik. Z Gastroenterol 16: 188–97
Cheng WS, Murphy TL, Smith MT, et al (1990) Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 47: 516–24
Fairchild R, Solomon H, Contis J, et al (1996) Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability. Arch Surg 131: 1099–102
Farinati F, Dalri L, Rossaro L, et al (1993) Serum and salivary caffeine clearance in cirrhosis. Any role in selection for surgery and timing for transplantation? J Hepatol 18: 135–6
Friedman LS, Martin P, Muñoz SJ (1996) Liver function tests and the objective evaluation of the patient with liver disease. In: Zakim D, Boyer T (ed) Hepatology — A textbook of liver disease. 3rd edn. W.B. Saunders, New York, pp. 791–833
Giannini EG, Fasoli A, Borro P, et al (2005) 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol 3: 279–285
Herold C, Ganslmayer M, Ocker M, et al (2003) Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve. J Gastroenterol Hepatol 18: 445–9
Jalan R, Hayes PC (1995) Quantitative tests of liver function. Aliment Pharmacol Ther 9: 263–70
Lewis FW, Rector WG Jr (1992) Caffeine clearance in cirrhosis. The value of simplifi ed determinations of liver metabolic capacity. J Hepatol 14: 157–62
Lotterer E, Högel J, Gaus W, et al (1997) Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study. Hepatology 26: 1426–33
Maynard ND, Bihari DJ, Dalton RN, et al (1997) Liver function and splanchnic ischemia in critically ill patients. Chest 111: 180–7
Merkel C, Gatta A, Zoli M, et al (1991) Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 36: 1197–203
Merkel C, Bolognesi M, Bellon S, et al (1992) Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 33: 836–42
Merkel C, Marchesini G, Fabbri A, et al (1996) The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology 24: 820–3
Meyer-Wyss B, Renner E, Luo H, et al (1993) Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. J Hepatol 19: 133–9
Molino G, Cavanna A, Avagnina P, et al (1987) Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma fl ow. Dig Dis Sci 32: 753–8
Park GJH, Katelaris PH, Jones DB, et al (2003) Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 38: 1227–36
Paumgartner G (1975) The handling of indocyanine green by the liver. Schweiz Med Wschr 105(Suppl): 1–30
Preisig R (1985) Fremdsubstanzen als Indikatoren der Leberfunktion. Schweiz Med Wschr Suppl 19: 36–42
Reichen J, Widmer T, Cotting J (1991) Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. Hepatology 14: 504–10
Rosenthal SM, White EC (1925) Clinical application of bro-msulphthalein test for hepatic function. JAMA 84: 1112
Rowntree LG, Hurwitz SH, Bloomfi eld AL (1913) An experimental and clinical study of the value of phenoltetra-chlorphthalein as a test of hepatic function. Bull Johns Hopkins Hosp 24: 327
Salerno F, Borroni G, Moser P, et al (1996) Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. J Hepatol 25: 474–80
Schmidt LE, Ott P, Tygstrup N (2004) Galactose elimination capacity as a prognostic marker in patients with severe acet-aminophen-induced hepatotoxicity: 10 years' experience. Clin Gastroenterol Hepatol 2: 418–24
Shiffman ML, Luketic VA, Sanyal AJ, et al (1994) Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis. Hepatology 19: 933–40
Stremmel W, Wojdat R, Groteguth R, et al (1992) Leberfunktionstests im klinischen Vergleich. Z Gastroenterol 30: 784–90
Tygstrup N (1990) Assessment of liver function: principles and practice. J Gastroenterol Hepatol 5: 468–82
Wahlländer A, Beuers U (1990) Prognostischer Wert von Leberfunktionstests – Klinik, laborchemische Parameter und quantitative Funktionstests. Leber Magen Darm 20:115– 6, 119–23, 126–8
Wahlländer A, Mohr S, Paumgartner G (1990) Assessment of hepatic function. Comparison of caffeine clearance in serum and saliva during the day and at night. J Hepatol 10: 129–37
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dancygier, H. (2010). Tests of Liver Function. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-93842-2_35
Download citation
DOI: https://doi.org/10.1007/978-3-540-93842-2_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-93841-5
Online ISBN: 978-3-540-93842-2
eBook Packages: MedicineMedicine (R0)